Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury

Completed

• Conditions: Traumatic Brain Injury

• Registration Number: NCT03534154
• Lead Sponsor: Imperial College London

Brief Summary

Observational longitudinal study assessing outcomes following moderate-severe traumatic brain injury (TBI).

Detailed Description

Traumatic brain injury (TBI) occurs when the brain is physically damaged, for example after a car crash. It is common and survivors often have major on-going problems. It is very difficult to predict how patients will do after TBI. One reason for this is that clinicians and researchers are unable to measure all the effects of TBI. An important factor is that the connections between nerve cells are damaged by the impact on the brain of an injury (axonal injury). This damage has been difficult to measure in the past, but new ways to scan the brain and more sensitive ways of picking up the effects of this injury in the blood could change this. In other parts of medicine tests of this type have had a dramatic effect on how clinicians treat patients. For example, the products of heart muscle damage that have leaked into the blood can be used identify a heart attack and guide treatment. Clinicians need similar tests to be available in TBI. This should be possible as the products of axonal injury also leak into the blood and researchers have a sensitive way to pick this up. An accurate test for axonal injury would guide treatment choices and allow clinicians to predict how patients will recover. The investigators have brought together an international team who have been working on different aspects of this problem for many years. Together the investigators will conduct a large study to identify the best measures of axonal injury. The investigators will carefully test whether these measures help predict outcomes and will study where the blood markers come from using a safe method to measure the effects of axonal injury directly from the brain. The work links into some large projects that have already started and will use a standard way to assess patients after their injury. This is important because it will allow researchers to share results across studies. The investigators hope the work will allow us to identify a blood marker for TBI that could be widely used to quickly identify the presence of axonal injury. The investigators will also show what brain imaging measure is best at picking up axonal injury and how best to combine the measures to best predict how patients recover. This will allow doctors to diagnose problems after TBI more accurately, choose the right treatments and give patients and their families accurate advice about what will happen after discharge from hospital.

Study Timeline

• Study Start: 2017-11-30
• Study First Submitted: 2018-04-27
• Study First Submitted QC: 2018-05-11
• Study First Posted: 2018-05-23
• Primary Completion: 2021-04-30
• Study Completion: 2021-12-30
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-29
• Last Update Posted: 2022-03-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 313

Inclusion Criteria

• A diagnosis of moderate/severe traumatic brain injury (TBI) as classified using the Mayo classification system;
• Healthy controls will be age-matched to our TBI patients and will not have a history of significant neurological or psychiatric conditions.

Exclusion Criteria

• Unwillingness or inability to follow the procedures required
• Bilateral fixed dilated pupils
• For MRI, contra-indication to MRI scanning, assessed by a standard pre-MRI questionnaire (e.g. presence of ferromagnetic implants in the body, claustrophobia, pregnancy) if considered for the imaging strand of the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in levels of fluid biomarkers in blood	0-5 days, 5-10 days, 10 days - 6 weeks, 6 months and 12 months	Neurofilament light and Tau protein
Change in diffusion tensor imaging measures over time	10 days - 6 weeks, 6 months and 12 months	Fractional anisotropy (FA)
Brain atrophy rates	10 days - 6 weeks, 6 months and 12 months	Brain tissue volume changes over time.
Change in levels of fluid biomarkers in cerebral fluid	48 hours to 7 days	Neurofilament light and Tau protein

Trial Locations

Locations (5)

Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico; 🇮🇹 Milan, Italy

IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri"; 🇮🇹 Milan, Italy

University Medical Centre; 🇸🇮 Ljubljana, Slovenia

Centre Hospitalier Universitaire Vaudois; 🇨🇭 Lausanne, Switzerland

Imperial College London; 🇬🇧 London, United Kingdom